|
POLG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.256070E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.355300E-03 |
| Normal-vs-Stage2 |
7.66130000000587E-05 |
| Normal-vs-Stage3 |
1.818530E-03 |
| Normal-vs-Stage4 |
7.220200E-02 |
| Stage1-vs-Stage2 |
5.580200E-02 |
| Stage1-vs-Stage3 |
5.606000E-01 |
| Stage1-vs-Stage4 |
4.582800E-01 |
| Stage2-vs-Stage3 |
2.165400E-01 |
| Stage2-vs-Stage4 |
3.375800E-02 |
| Stage3-vs-Stage4 |
3.150000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.015300E-03 |
| Normal-vs-AfricanAmerican |
1.336190E-01 |
| Normal-vs-Asian |
5.636000E-02 |
| Caucasian-vs-AfricanAmerican |
6.123000E-01 |
| Caucasian-vs-Asian |
6.651400E-01 |
| AfricanAmerican-vs-Asian |
8.644400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.183740E-02 |
| Normal-vs-Female |
7.986800E-04 |
| Male-vs-Female |
4.636400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.342600E-03 |
| Normal-vs-Age(41-60Yrs) |
4.432900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.258250E-03 |
| Normal-vs-Age(81-100Yrs) |
3.592600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.557160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.174200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.822000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.356800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.450400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.496000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.296600E-01 |
| Classical-VS-Follicular |
1.15549791956937E-11 |
| Classical-VS-Other |
1.476850E-01 |
| Classical-VS-Normal |
5.479800E-02 |
| Tall-VS-Follicular |
1.845870E-04 |
| Tall-VS-Other |
2.434000E-01 |
| Tall-VS-Normal |
1.733020E-01 |
| Follicular-VS-Other |
4.174400E-01 |
| Follicular-VS-Normal |
1.90820026446659E-10 |
| Other-VS-Normal |
2.184300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.01299999999361E-05 |
| Normal-vs-N1 |
5.439800E-03 |
| N0-vs-N1 |
4.825000E-01 |
|
|
